Skip to content

Somatosensory Profiles through quantitative sensory testing of patients with rheumatological diseases

Somatosensory Profiles through quantitative sensory testing of patients with rheumatological diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030326
Enrollment
100
Registered
2022-09-22
Start date
2022-10-06
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M06 M45 M34 M07

Interventions

Group 1: Patients with the diagnosis spondylarthritis: One time testing through quantitative sensory Testing including a questionnaire on the clinical manifestation of the disease Group 2: Patients wi

Sponsors

Universitätsklinikum Bonn
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Person in the age range of 18-65 years Confirmed diagnosis of the following underlying rheumatological disease: - Rheumatoid arthritis according to the 2010 Amercian College of Rheumatology (ACR) criteria. - Systemic sclerosis according to the 2013 ACR/EULAR classification criteria. - Ankylosing spondylitis according to the ASAS criteria - Psoriatic arthritis according to the 2010 American College of Rheumatology (ACR) criteria. Prior informed consent and informed written consent.

Exclusion criteria

Exclusion criteria: Inability to give informed and written consent. Contraindications to the use of QST: - Skin and soft tissue diseases. - Pregnancy - Nursing Period

Design outcomes

Primary

MeasureTime frame
Detection of deviations in the pain profile/somatosensory profile by means of a one-time testing using quantitative sensory testing (QST) in patients with rheumatoid arthritis (rheumatoid arthritis, psoriatic arthritis, systemic sclerosis, spondylarthritis).

Secondary

MeasureTime frame
Recording of the relation between individual parameters of the QST and information in the questionnaire on disease activity, medication, laboratory parameters and organ manifestation.

Countries

Germany

Contacts

Public ContactRuth Schrapper

Universitätsklinikum Bonn

ruth.schrapper@uni-bonn.de015778835496

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026